Search

everythinglearnresearchcommunity

for

Search:↓

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

The patient's hair loss is most likely due to diffuse alopecia areata.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Cyclosporine can treat skin conditions but needs careful monitoring for side effects.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Topical cyclosporin A may help treat psoriasis but has absorption and side effect challenges.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

A cat with skin bumps and itching had high blood fats and skin infections, which improved with diet and medication changes.

Stress hormones like cortisol may trigger psoriasis flare-ups.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Careful management of blood thinners is crucial for lupus patients with APS.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

A 7-year-old dog with a rare autoimmune disease was euthanized due to severe anemia and poor prognosis.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A dog developed a skin condition called pemphigus foliaceus after taking NexGard, but got better with treatment.